Publications powered by Harvard Catalyst Profiles

1. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. Gastroenterology. 2020 Aug; 159(2):591-608.e10. View abstract
2. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis. 2020 05 12; 26(6):820-842. View abstract
3. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. Inflamm Bowel Dis. 2019 11 14; 25(12):1927-1938. View abstract
4. Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease. PLoS One. 2019; 14(10):e0222952. View abstract
5. The pharmacotherapeutic management of pediatric Crohn's disease. Expert Opin Pharmacother. 2019 Dec; 20(17):2161-2168. View abstract
6. Natural history of children with mild Crohn's disease. World J Gastroenterol. 2019 08 14; 25(30):4235-4245. View abstract
7. Commentary: Monitoring Thiopurine Efficacy Without Levels: Is It a Good Idea? J Pediatr Gastroenterol Nutr. 2019 07; 69(1):1-2. View abstract
8. Microscopic/"Backwash" Ileitis and Its Association With Colonic Disease in New Onset Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2019 06; 68(6):835-840. View abstract
9. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S40-S47. View abstract
10. Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary. Gut. 2020 01; 69(1):32-41. View abstract
11. Microscopic / "Backwash" Ileitis and its Association with Colonic Disease in New Onset Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2019 Jan 21. View abstract
12. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. Inflamm Bowel Dis. 2019 01 01; 25(1):27-32. View abstract
13. Reducing Redundant Anaerobic Therapy Through Spaced Education and Antimicrobial Stewardship Interventions. J Pediatric Infect Dis Soc. 2018 Dec 03; 7(4):317-322. View abstract
14. Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. Inflamm Bowel Dis. 2018 11 29; 24(12):2565-2578. View abstract
15. Curved planar reformatting and convolutional neural network-based segmentation of the small bowel for visualization and quantitative assessment of pediatric Crohn's disease from MRI. J Magn Reson Imaging. 2019 06; 49(6):1565-1576. View abstract
16. The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 05 18; 24(6):1344-1351. View abstract
17. Educational needs in the diagnosis and management of pediatric functional constipation: a US survey of specialist and primary care clinicians. Postgrad Med. 2018 May; 130(4):428-435. View abstract
18. Commentary: Button Batteries in Fidget Spinners: Is It Time to Push the "Panic Button"? J Pediatr Gastroenterol Nutr. 2018 04; 66(4):557-558. View abstract
19. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children. Clin Gastroenterol Hepatol. 2018 09; 16(9):1467-1473. View abstract
20. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial. Gut. 2019 02; 68(2):239-247. View abstract
21. Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab. J Pediatr Surg. 2018 Jul; 53(7):1330-1333. View abstract
22. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflamm Bowel Dis. 2017 11; 23(11):1950-1961. View abstract
23. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J Exp Med. 2017 Jul 03; 214(7):1937-1947. View abstract
24. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. World J Gastroenterol. 2017 May 14; 23(18):3322-3329. View abstract
25. Outcomes From Pediatric Gastroenterology Maintenance of Certification Using Web-based Modules. J Pediatr Gastroenterol Nutr. 2017 05; 64(5):671-678. View abstract
26. From "Jarts" to "Zen Magnets": Protecting Our Children from Dangerous Toys. J Pediatr. 2017 07; 186:6-7. View abstract
27. O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. Inflamm Bowel Dis. 2017 Feb; 23 Suppl 1:S4. View abstract
28. Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression. J Pediatr Gastroenterol Nutr. 2016 12; 63(6):658-664. View abstract
29. Interleukin 1ß Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology. 2016 12; 151(6):1100-1104. View abstract
30. Postoperative Complications in Children With Crohn Disease Treated With Infliximab. J Pediatr Gastroenterol Nutr. 2016 09; 63(3):352-6. View abstract
31. Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents. J Pediatr. 2016 Nov; 178:227-232. View abstract
32. NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-a Inhibitors. J Pediatr Gastroenterol Nutr. 2016 07; 63(1):130-55. View abstract
33. O-017 YI Inflammatory Versus Non-inflammatory Predictors of Specific Depressive Symptoms in a Large Pediatric Cohort with IBD. Inflamm Bowel Dis. 2016 Mar; 22 Suppl 1:S6. View abstract
34. Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders. Inflamm Bowel Dis. 2015 Oct; 21(10):2281-8. View abstract
35. Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. Inflamm Bowel Dis. 2015 Aug; 21(8):1750-1. View abstract
36. Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. Inflamm Bowel Dis. 2015 Jun; 21(6):1321-8. View abstract
37. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. J Pediatr. 2015 Sep; 167(3):527-32.e1-3. View abstract
38. Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease. Clin Gastroenterol Hepatol. 2015 Oct; 13(10):1748-56. View abstract
39. Surgical management and morbidity of pediatric magnet ingestions. J Surg Res. 2015 Nov; 199(1):137-40. View abstract
40. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. Inflamm Bowel Dis. 2015 Feb; 21(2):307-14. View abstract
41. Functional significance of single nucleotide polymorphisms in the lactase gene in diverse US patients and evidence for a novel lactase persistence allele at -13909 in those of European ancestry. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):182-91. View abstract
42. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015 Feb; 39(2):245-50. View abstract
43. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study. Gut. 2015 Dec; 64(12):1898-904. View abstract
44. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Aug; 20(8):1329-40. View abstract
45. Benefit/risk assessment of biologic monotherapy vs combination therapy in Crohn's Remains Challenging. Gastroenterology. 2014 Aug; 147(2):540. View abstract
46. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease. Inflamm Bowel Dis. 2014 Jun; 20(6):1015-20. View abstract
47. Pediatric ulcerative colitis: a practical guide to management. Paediatr Drugs. 2014 Jun; 16(3):189-98. View abstract
48. Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. Gastroenterol Hepatol (N Y). 2014 Jun; 10(6):355-63. View abstract
49. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014 Jul; 53(7):726-35. View abstract
50. Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):569-73. View abstract
51. Authors' response. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):e51. View abstract
52. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):574-81. View abstract
53. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014 Apr 09; 14:71. View abstract
54. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):309-18. View abstract
55. Advocating for child health: how the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition took action against high-powered magnets. J Pediatr. 2014 Jan; 164(1):4-5.e1. View abstract
56. NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):130-8. View abstract
57. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):e44-100. View abstract
58. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):343-7. View abstract
59. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):293-7. View abstract
60. Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):335-42. View abstract
61. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. J Pediatr Surg. 2013 Jul; 48(7):1540-5. View abstract
62. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One. 2013; 8(6):e63686. View abstract
63. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jun; 19(7):1441-9. View abstract
64. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):826-31. View abstract
65. Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum. Expert Rev Clin Immunol. 2013 Feb; 9(2):117-27. View abstract
66. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013 Jan; 56(1):12-8. View abstract
67. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013 Jan; 19(1):96-109. View abstract
68. Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. J Clin Psychol Med Settings. 2012 Sep; 19(3):329-37. View abstract
69. Management of ingested magnets in children. J Pediatr Gastroenterol Nutr. 2012 Sep; 55(3):239-42. View abstract
70. Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn's disease. J Magn Reson Imaging. 2013 Jan; 37(1):156-63. View abstract
71. Budesonide use in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2012 Aug; 55(2):200-4. View abstract
72. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012 Sep; 107(9):1399-406. View abstract
73. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012; 7(6):e39242. View abstract
74. An i2b2-based, generalizable, open source, self-scaling chronic disease registry. J Am Med Inform Assoc. 2013 Jan 01; 20(1):172-9. View abstract
75. Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor. Compr Psychiatry. 2012 Nov; 53(8):1194-9. View abstract
76. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr 16; 13(9):R79. View abstract
77. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2012 May; 18(5):935-42. View abstract
78. Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. Inflamm Bowel Dis. 2012 May; 18(5):838-43. View abstract
79. "Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis. J Clin Gastroenterol. 2011 Jul; 45(6):479-80. View abstract
80. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr. 2011 Jun; 52(6):708-13. View abstract
81. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol. 2011 May; 106(5):981-7. View abstract
82. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011 Apr; 106(4):574-88. View abstract
83. Innate and adaptive immune connections in inflammatory bowel diseases. Curr Opin Gastroenterol. 2010 Nov; 26(6):572-7. View abstract
84. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflamm Bowel Dis. 2011 Jan; 17(1):22-9. View abstract
85. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):140-5. View abstract
86. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Expert Rev Clin Immunol. 2010 Jul; 6(4):659-66. View abstract
87. Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol. 2010 Sep; 8(9):789-94. View abstract
88. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J Pediatr Gastroenterol Nutr. 2010 May; 50(5):562-5. View abstract
89. Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol. 2010 Jun; 105(6):1430-6. View abstract
90. Probiotic for new onset ulcerative colitis in children: baby's got bac(teria). Inflamm Bowel Dis. 2010 Jan; 16(1):177-8. View abstract
91. Monitoring Disease Activity in Pediatric IBD Patients (monograph). Children's Digestive Health and Nutrition Foundation 2009 . 2010. View abstract
92. Healthcare burden of inflammatory bowel disease in the United States: more than pain and diarrhea. Inflamm Bowel Dis. 2009 Nov; 15(11):1767-8. View abstract
93. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009 Sep; 15(9):1417-23. View abstract
94. Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2009 Sep; 49(3):297-303. View abstract
95. Restorative proctocolectomy and ileal pouch-anal anastomosis in children. Dis Colon Rectum. 2009 Sep; 52(9):1645-9. View abstract
96. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009 Aug; 15(8):1218-23. View abstract
97. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis. 2009 Jun; 15(6):816-22. View abstract
98. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis. 2009 Mar; 15(3):383-7. View abstract
99. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr. 2009 Feb; 48(2):168-74. View abstract
100. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009 Feb; 104(2):444-53. View abstract
101. Making the right diagnosis: differentiating between Crohn disease and ulcerative colitis in children and young adults. . 2009. View abstract
102. Approach to clinical diagnosis of inflammatory bowel disease. In: Walker-Smith JA, Lebenthal E, Branski D. Pediatric Inflammatory Bowel Disease: Perspective and consequences. 2009; 123-137. View abstract
103. Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res. 2008 Aug; 52(8):867-74. View abstract
104. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis. 2008 Jul; 14(7):949-54. View abstract
105. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008 Apr; 20(4):269-84. View abstract
106. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis. 2008 Jan; 40(1):32-8. View abstract
107. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007 Oct; 46(10):1290-1298. View abstract
108. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec; 5(12):1424-9. View abstract
109. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007 Nov; 151(5):523-7. View abstract
110. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007 Jul; 13(7):890-5. View abstract
111. Challenges and progress in pediatric inflammatory bowel disease. Curr Opin Gastroenterol. 2007 Jul; 23(4):406-12. View abstract
112. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. 2007 Jun; 119(6):1113-9. View abstract
113. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007 May; 44(5):653-74. View abstract
114. Pete Learns About Crohn's and Colitis. 2007. View abstract
115. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007 Jan; 42(1):31-4; discussion 34-5. View abstract
116. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006 Dec; 12(12):1101-6. View abstract
117. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Sep; 12(9):885-913. View abstract
118. Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers. Inflamm Bowel Dis. 2006 Aug; 12(8):814-23. View abstract
119. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Aug; 12(8):684-91. View abstract
120. Medical therapy for refractory pediatric Crohn's disease. Clin Gastroenterol Hepatol. 2006 Oct; 4(10):1199-213. View abstract
121. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1124-9. View abstract
122. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1118-23. View abstract
123. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis. 2006 Apr; 12(4):251-7. View abstract
124. Gastrointestinal issues in developmentally disabled children. LI Rubin and AC Crocker eds. Medical Care for children and adults with developmental disabilities. 2006; 307-324. View abstract
125. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006; 8(5):279-302. View abstract
126. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005 Oct; 41(4):416-21. View abstract
127. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005 Sep; 11(9):833-9. View abstract
128. Workshop report: prevention of postoperative recurrence in Crohn's disease. J Pediatr Gastroenterol Nutr. 2005 Aug; 41(2):145-51. View abstract
129. Normal homocysteine levels in a population of children with inflammatory bowel disease. Inflamm Bowel Dis. 2005 Jun; 11(6):620-1. View abstract
130. Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis. 2005 Jun; 11(6):519-27. View abstract
131. A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis. 2005 Feb; 11(2):185-96. View abstract
132. Probiotic Therapies: the crossroads of traditional and alternative medicine. Practical Gastroenterology. 2005; 4:20-36. View abstract
133. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004 Nov; 99(11):2235-41. View abstract
134. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2004 Oct; 39(4):395-403. View abstract
135. Mucosal healing in children with Crohn's disease: appropriate therapeutic goal or medical overkill? Inflamm Bowel Dis. 2004 Jul; 10(4):481-3. View abstract
136. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004 Feb; 28(2):190-7. View abstract
137. Immunosuppressive therapies. Walker WA, Goulet O, Kleinman R, Sherman P, Shneider B, Sanderson I eds. Pediatric Gastrointestinal Disease. 2004; 2:2015-2044. View abstract
138. Pediatric Crohn's disease. Johnson L ed. Encyclopedia of Gastroenterology. 2004; 520-527. View abstract
139. Ulcerative colitis. Guandalini ed, Textbook of Pediatric Gastroenterology. 2004; 385-418. View abstract
140. Gastroenterologic and Liver Disorders. Stiehm ER, Ochs H, Winkelstein J eds. Immunologic disorders in infants and children. 2004; 1055-1102. View abstract
141. Gastroenterology questions for the American Academy of Pediatrics PREP course. Available on www.pedialink.org. 2004. View abstract
142. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol. 2003 Dec; 98(12):2712-8. View abstract
143. Blocking lymphocyte adhesion: new treatment for sticky cases of Crohn disease? J Pediatr Gastroenterol Nutr. 2003 Aug; 37(2):211-3. View abstract
144. Isolated neonatal swallowing dysfunction: a case series and review of the literature. Dig Dis Sci. 2003 Jan; 48(1):30-5. View abstract
145. Webcast: Crohn's and colitis Foundation - Management of IBD in special populations. Available on www.ccfa.org. 2003. View abstract
146. Nutritional therapy of inflammatory bowel disease. Caballero B, Trugo L, Finglas P eds. Encyclopedia of Food Sciences and Nutrition. 2003; 3315-3320. View abstract
147. Feeding tubes. Puder M, Hansen A eds. Manual of Neonatal Surgical Care. 2003; 303-314. View abstract
148. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002 Nov; 47(11):2625-34. View abstract
149. Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2002 Nov; 35(5):695-9. View abstract
150. Blame Canada: growing questions about budesonide. Inflamm Bowel Dis. 2002 May; 8(3):235. View abstract
151. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol. 2002 Feb; 97(2):382-8. View abstract
152. Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 3:S286-90. View abstract
153. Board review questions in pediatric gastroenterology for the American Academy of Pediatrics PREP the course. 16 Questions per year for 6 years (2002-2008). 2002. View abstract
154. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):602-5. View abstract
155. Inflammatory bowel disease associated with immune thrombocytopenic purpura in children. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):582-7. View abstract
156. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):548-53. View abstract
157. Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. J Pediatr Gastroenterol Nutr. 2001 Aug; 33(2):149-54. View abstract
158. Thalidomide in gastrointestinal disorders. Drugs. 2001; 61(6):777-87. View abstract
159. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001 Jan; 120(1):13-20. View abstract
160. Epidemiology and diagnosis of inflammatory bowel disease. Bonis ed., Up to Date. 2001; 9. View abstract
161. The spectrum of pediatric gastroesophageal reflux. JAMA. 2000 Dec 27; 284(24):3125-6. View abstract
162. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000 Dec; 137(6):794-9. View abstract
163. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999 Dec; 44(12):2500-7. View abstract
164. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol. 1999 Apr; 23(4):390-6. View abstract
165. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci. 1999 Feb; 44(2):424-30. View abstract
166. Crohn's disease in children and adolescents. Bonis ed, Up to Date (CD-ROM). 1999; 8. View abstract
167. Gastrointestinal Manifestations of Primary Immunodeficiencies. Wyllie R, Hyams JS. Pediatric Gastrointestinal Disease. 1999; 381-389. View abstract
168. Ulcerative Colitis in children and adolescents. Bonis ed, Up to Date (CD-ROM). 1999. View abstract
169. Gastrointestinal issues in the child with developmental disabilities. International Seminars in Pediatric Gastroenterology and Nutrition. 1999; 8:1-9. View abstract
170. Intraduodenal hematoma complicating intestinal biopsy: case reports and review of the literature. Am J Gastroenterol. 1998 Dec; 93(12):2547-50. View abstract
171. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med. 1998 Nov; 152(11):1132-6. View abstract
172. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol. 1998 Nov; 26(5):365-9. View abstract
173. Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1998 May; 26(5):500-5. View abstract
174. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998 Feb; 26(2):129-35. View abstract
175. Clinical outcome of ulcerative proctitis in children. J Pediatr Gastroenterol Nutr. 1997 Aug; 25(2):149-52. View abstract
176. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes. Dig Dis Sci. 1997 Jul; 42(7):1542-8. View abstract
177. Preventing relapse after surgery for Crohn's disease: where do we go from here? J Pediatr Gastroenterol Nutr. 1997 Jul; 25(1):114-5. View abstract
178. Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. Dig Dis Sci. 1997 Feb; 42(2):378-86. View abstract
179. Immunosuppressive Agents in Gastrointestinal Disease. Kresina T, ed. Manual of Immune Modulating Agents. 1997. View abstract
180. Gastroenterologic Disorders. Graef J, Priebe C eds. Manual of Pediatric Therapeutics. 1997. View abstract
181. Tacrolimus (FK-506) treatment of fulminant colitis in a child. J Pediatr Gastroenterol Nutr. 1996 Oct; 23(3):329-33. View abstract
182. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1996 Aug; 23(2):164-71. View abstract
183. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology. 1996 Jul; 111(1):237-43. View abstract
184. Immunosuppressive therapies in Pediatric Gastroenterology. Walker WA, Hamilton JR, Watkins JB, Walker-Smith JA, Durie PR. Pediatric Gastrointestinal Disease. 1995. View abstract
185. Immunosuppressive Agents in Gastrointestinal Disease. Current Opinion in Gastroenterology. 1995; 11:554-561. View abstract
186. Immunology and Gastrointestinal Disease. Stiehm ER ed, Immunologic Disorders of Infants and Children. 1995; 697-741. View abstract
187. New immunotherapies and their potential for treatment of inflammatory bowel disease. Progress in Inflammatory Bowel Disease. 1993; 14:6-11. View abstract
188. Immunology and Gastrointestinal Disease. Wyllie R and Hyams J eds., Pediatric Gastrointestinal Disease. 1993; 64-73. View abstract
189. Basic gastrointestinal immunology. Bouchier IA, Hodgson HJ, Keighley MR eds., Gastroenterology: Clinical Science and Practice. 1993; 577-582. View abstract
190. Ringed esophagus: an association with esophagitis. Am J Gastroenterol. 1992 Sep; 87(9):1187-90. View abstract
191. Development of the Intestinal Mucosal Barrier. McDonald TT ed, Ontogeny of the Immune System of the Gut. 1991. View abstract
192. Abdominal Wall Defects. Rudolph Textbook of Pediatrics. 1991; 1040-1042. View abstract
193. Diarrhea in the Immunodeficient Host. Rudolph's Textbook of Pediatrics. 1991; 1012-1015. View abstract
194. Imaging of neuroblastoma: an overview. Pediatr Radiol. 1986; 16(2):89-106. View abstract
195. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. Am J Pathol. 1985 Dec; 121(3):514-21. View abstract